Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.820
+0.320 (7.11%)
At close: Aug 22, 2025, 4:00 PM
4.890
+0.070 (1.45%)
After-hours: Aug 22, 2025, 6:07 PM EDT

Monte Rosa Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
177.9975.62----
Upgrade
Cost of Revenue
121.44112.86103.37---
Upgrade
Gross Profit
56.55-37.24-103.37---
Upgrade
Selling, General & Admin
41.5943.8739.9435.1215.734.01
Upgrade
Research & Development
---77.2657.1624.01
Upgrade
Operating Expenses
41.5943.8739.94112.3872.8828.01
Upgrade
Operating Income
14.96-81.11-143.31-112.38-72.88-28.01
Upgrade
Interest & Investment Income
11.9910.579.333.760.050.01
Upgrade
Currency Exchange Gain (Loss)
1.410.42-0.930.01-0.16-0.2
Upgrade
Other Non Operating Income (Expenses)
-----0.96-7.68
Upgrade
EBT Excluding Unusual Items
28.37-70.13-134.91-108.61-73.96-35.88
Upgrade
Gain (Loss) on Sale of Investments
---0.13---
Upgrade
Gain (Loss) on Sale of Assets
0.06-0.020.11--
Upgrade
Pretax Income
28.42-70.13-135.01-108.5-73.96-35.88
Upgrade
Income Tax Expense
4.262.570.34---
Upgrade
Net Income
24.17-72.7-135.35-108.5-73.96-35.88
Upgrade
Net Income to Common
24.17-72.7-135.35-108.5-73.96-35.88
Upgrade
Shares Outstanding (Basic)
82745147252
Upgrade
Shares Outstanding (Diluted)
83745147252
Upgrade
Shares Change (YoY)
38.55%43.80%8.83%88.91%1548.09%7.11%
Upgrade
EPS (Basic)
0.29-0.98-2.63-2.30-2.96-23.65
Upgrade
EPS (Diluted)
0.29-0.98-2.63-2.30-2.96-23.65
Upgrade
Free Cash Flow
23.8538.01-62.84-105.38-69.1-26.44
Upgrade
Free Cash Flow Per Share
0.290.51-1.22-2.23-2.76-17.43
Upgrade
Gross Margin
31.77%-49.25%----
Upgrade
Operating Margin
8.40%-107.26%----
Upgrade
Profit Margin
13.58%-96.14%----
Upgrade
Free Cash Flow Margin
13.40%50.26%----
Upgrade
EBITDA
23.3-72.99-137.09-108.64-70.75-27.47
Upgrade
EBITDA Margin
13.09%-96.52%----
Upgrade
D&A For EBITDA
8.348.126.223.752.130.54
Upgrade
EBIT
14.96-81.11-143.31-112.38-72.88-28.01
Upgrade
EBIT Margin
8.40%-107.26%----
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q